Demegen-Pacgen licensing deal announced

03/23/2005 | American City Business Journals

Pennsylvania-based Demegen said it licensed certain peptides to Pacgen Biopharmaceuticals, a Vancouver, British Columbia, firm specializing in drug design and development for infectious diseases and immune system regulations. Pacgen's CEO said the move would help his firm move products to the market more quickly.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA